Autoinjector Market Worth USD 104.9 Billion : Growing Prevalence Of Targeted Therapies And Technological Advancements

 Expected Revenue Growth:

[180 Pages Report] The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025.

What This Report Will Provide?

This study involved four major activities in estimating the current autoinjectors market size. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the number of breast lesion localization procedures and the value market.

Major Growth Boosters:

Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724  

COVID-19 Impact on The Autoinjectors :

The COVID-19 pandemic has resulted in a global healthcare crisis, causing a shift in healthcare delivery in most regions. Most non-essential procedures and in-hospital therapies were deferred in the first half of 2020 to prevent the spread of the infection and ease the toll on healthcare infrastructure.

Recent Developments :

• In August 2020, Antares Pharma (US) signed an agreement with Lunatus Global Medical Supplies (Dubai). In this agreement, Antares will supply packaged products to Lunatus and Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia as well as promote, market, and distribute XYOSTED in these two countries.
• In March 2020, SHL Medical (Switzerland) acquired Weibel CDS (Switzerland). This acquisition aimed at strengthening SHL Medical’s ability to provide more advanced drug delivery systems based on human-centered designs and functionality.
• In January 2020, Eli Lilly invested USD 470 million and created over 460 new jobs in Durham, NC. This expansion brought a new state-of-the-art pharmaceutical manufacturing facility to North Carolina’s research triangle park.

Frequently Asked Questions (FAQ):

• Which are the top industry players in the global autoinjectors market?
• What are the top trends in the autoinjectors market?
• Which autoinjectors market, by therapy, have been included in this report?
• Which geographical region is dominating in the autoinjectors market?
• Which is the leading therapy in the autoinjectors market?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724  

Need to limit patient visits and physical contact :

The current COVID-19 pandemic has resulted in the implementation of a fresh set of protocols that aim to reduce patient visits to hospitals and clinics in non-emergency conditions to prevent both the transmission of the virus as much as make sure healthcare institutions are not overwhelmed. In this situation, the preference for home-use autoinjectors has risen among patients suffering from chronic illnesses and allergies. This also protects vulnerable high-risk populations from exposure to the virus during hospital visits.

Regional Growth Analysis:

Geographically, the autoinjectors market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the Asia Pacific market is majorly driven by the large diabetes population and increasing healthcare expenditure which has drawn a number of major autoinjector device manufacturers to this region. These companies are increasing their presence in the Asia Pacific market through several approaches, such as establishing sales offices and partnering with local pharmaceutical companies.

Transfer Membrane Market Worth USD 187.9 : Current Status, Statistics, Growth Dynamics And Future Trends

 What This Report Will Provide?

This research study involved the usage of extensive secondary sources, directories, and databases such as D&B, Bloomberg Business, and Factiva, along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the transfer membrane market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

Expected Revenue Growth:

[124 Pages Report] The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Major Growth Boosters:

Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865 

Objectives of the study are:

• To define, describe, and forecast the market by type, transfer method, application, end user, and region
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities) along with the current trends
• To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the revenue of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Based on end user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=36975865 

On the basis of type, the market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF Membranes are expected to command for the major share of the market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.

Regional Growth Analysis:

North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region.

Bioinformatics Services Market Worth USD 3.53 Billion : Growing Applications Of Bioinformatics In Various Industries

 What This Report Will Provide?

The bioinformatics services market, by application, is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and other applications. The significant growth of the segment is attributed to the rising demand for more efficient data management facilities and the increasing number of research studies for the treatment of cancer using transcriptomics.

Expected Revenue Growth:

The global bioinformatics services market is expected to reach USD 3.53 billion by 2023 from USD 1.70 billion in 2018, at a CAGR of 15.7% during the forecast period.

Major Growth Boosters:

Growth in the global bioinformatics services market is mainly driven by the growing applications of bioinformatics in various industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects. The reducing cost of sequencing and growing volume of data generated during sequencing, growing focus on outsourcing for the management of large volumes of data, and the emerging markets are also expected to present growth opportunities for players in the market.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439 

Study Objectives:

• In 2017, QIAGEN and Centogene (Germany) collaborated to integrate Centogene’s CentoMD rare disease variant database with Qiagen Clinical Insight bioinformatics solution
• In 2017, NeoGenomics established its first European laboratory in Rolle, Switzerland to expand its geographical presence and increase its sales in Europe.
• In 2017, QIAGEN acquired OmicSoft Corporation (US) to enhance its multi-omics data analysis bioinformatics services offerings
• In 2016, Eurofins partnered with Institute of Genomics and Integrative Biology (IGIB, India) to launch their MitoSure-Human mitochondrial DNA sequencing and analysis pipeline to support research and genetic screening. The service includes automated bioinformatics analysis using IGIB proprietary Mit-O-Matic pipelineIn 2017, ConvaTec launched its Natura Convex Accordion Flange
• In 2015, PerkinElmer launched the PerkinElmer Signals Translational—a cloud-based data analysis platform

Key Questions Addressed in The Report:

• What are the growth opportunities related to bioinformatics service market across major regions in the future?
• Emerging countries have immense opportunities for the growth and adoption of bioinformatics service. Will this scenario continue in the next five years?
• What are the various bioinformatics service segments and their market share in the overall market?
• What are the new trends and advancements in the bioinformatics service market?

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439 

Growing applications of bioinformatics in various industries

In comparison with other conventional methods, bioinformatics services provide a wide range of advantages in terms of cost and time efficiency. Owing to these advantages, the applications of bioinformatics services are increasing in a number of fields such as toxicology, survival analysis, drug discovery and development, clinical diagnostics, disease prediction, and personalized medicine.

Regional Growth Analysis:

This report covers the bioinformatics services market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global bioinformatics services market in 2017, followed by Europe. The large share of the North American region is mainly attributed to the presence of leading bioinformatics service providers in the region, decreasing cost of sequencing, increasing number of genomic research activities in the region, high incidence of target diseases (such as cancer and genetic diseases), and favorable funding scenario for bioinformatics-based research.

Patient Monitoring Devices Market Worth USD 55.1 Billion – Statistics and Growth Dynamics To 2025

 What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Expected Revenue Growth:

[354 Pages Report] The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period.

Major Growth Boosters:

Integration of monitoring technologies in smartphones and wireless devices is a key trend in patient care, resulting in the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, ambulatory wireless EEG recorders, and ambulatory event monitors are the key factors supporting the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Recent Developments :

• In 2020, Medtronic received the US FDA approval for its LINQ II Insertable Cardiac Monitor (ICM). It is a implantable devices for determining the irregular heart rythm.
• In 2020, Medtronic and Tandem Diabetes Care, Inc underwent patent cross-license agreement, as per which both companies can cross-license each other’s patent portfolio for five years and jointly focus on innovating new products and services for diabetes management.
• In 2020, Masimo Corporation acquired the connected care business from NantHealth, which helped strengthen its position in the connected care market.

COVID-19 Impact on the global Patient Monitoring Devices market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Growing preference for wearable patient monitoring devices

Continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry are a few applications of wearable patient monitoring devices, biosensors, and smart implants. New-generation wearable devices are equipped with the Internet of Things technology. Vital signs such as blood pressure, weight, blood sugar, and electrocardiography (ECG) are measured using wearable biosensors and transmitted over mobile wireless networks to a central server.

Regional Growth Analysis:

The report covers the patient monitoring devices market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America, and MEA. North America commanded the largest share of the patient monitoring devices market in 2019. The increasing R&D to develop novel sensor based patient monitoring systems, rising prevalence of infectious diseases, safety concerns, and technological advancements in patient monitoring devices products are the key factors supporting market growth in North America.

Bioinformatics Market : Increasing Use Of Bioinformatics In Drug Discovery And Biomarker Development Process

 What This Report Will Provide?

Bioinformatics is the application of computer technology for the management and analysis of biological data. It includes collection, storage, retrieval, manipulation, and modelling of data for analysis, visualization, or prediction through algorithms and software.

Expected Revenue Growth:

[195 Pages Report] The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.

Major Growth Boosters:

Growth of the bioinformatics market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introduction of upcoming technologies such as nanopore sequencing (third generation sequencing technique) and cloud computing, the market is expected to offer significant opportunities for manufacturers of bioinformatics solutions.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39 

By Sector, medical biotechnology segment is expected to grow at the highest CAGR during the forecast period

Various pharmaceutical companies are increasingly adopting bioinformatics tools to decrease the cost and time involved in drug discovery. Bioinformatics approaches for target discovery and validation are proving more efficient than traditional methods. Pharma companies are also using AI along with bioinformatics tools to identify drug targets. Merck entered the AI space by collaborating with Numerate, Celgene partnered with GNS Healthcare, GSK collaborated with Exscientia, while Pfizer entered into a collaboration with IBM Watson for drug discovery research.

Bioinformatics in clinical diagnostics sector includes analysis of human genome with reference to disease diagnosis. This involves study of various omics technologies such as proteomics, metabolomics, metagenomics, epigenetics, and transcriptomics. Data generated through different omics technologies has assisted in the development of bioinformatics methodologies for clinical research and for building human databases. These computational approaches are then used to understand information about the origin, evolution, progression, and treatment of diseases, leading to the development of personalized medicine.

Key Questions Addressed in The Report:

• Who are the major market players in the bioinformatics market?
• What are the growth trends and the largest revenue-generating region for bioinformatics?
• How are bioinformatics products and services sold to customers?
• What are the major segments in bioinformatics market?
• What are the driving, restraining, opportunistic, and challenging factors for this market?

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=39 

IT giants investing in the development of bioinformatics solutions

IT giants have started focusing on bioinformatics for healthcare applications. Investments are being made for more advanced tests and techniques in battling diseases such as cancer and Parkinson’s. Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos have invested millions of dollars in Grail, a start-up by gene sequencing firm Illumina that a former Google executive leads. Grail is developing a cancer-screening blood test for people, even if they show no symptoms. The test’s development is expected to require many samples to be sequenced and analyzed by using more comprehensive bioinformatics tools and databases.

In 2018, The APAC market is expected to grow at the highest CAGR during the forecast period

The market in the Asia Pacific region is expected to offer significant opportunities for players to offset revenue losses incurred in mature markets. Emerging countries in this region are witnessing growth in their GDPs and a significant rise in disposable income levels. This has led to increased healthcare spending by a larger population base, healthcare infrastructure modernization, and rising penetration of cutting-edge research and clinical laboratory technologies, including bioinformatics, in Asia Pacific countries. These factors are expected to provide significant growth opportunities to bioinformatics companies operating in this region.

Medical Device Reprocessing Market To Reach USD 1,754 Million – Statistics & Growth Dynamics To 2022

 What This Report Will Provide?

The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent.

Expected Revenue Growth:The

global medical device reprocessing market is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016.

Major Growth Boosters:

The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat multiple patients.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=583 

Objectives of the Study

• To define, describe, and forecast the global market with respect to product & service, type of device, application, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
• To forecast the size of the market with respect to four main regions—North America, Europe, Asia-Pacific, and the Rest of the World

Target Audience:

• Third-party medical device reprocessors and distributors
• Hospitals, clinics, and other healthcare laboratories
• Academic and research institutions
• Government associations
• Market research and consulting firms
• Venture capitalists and investors

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=583 

The reprocessing practices are regulated by various regional regulatory authorities. The changing regulatory scenario favoring medical device reprocessing in a number of countries, such as France and Japan, will open up new areas of opportunity for market players. For example, till 2016, the outsourcing of medical device reprocessing was prohibited in France; however, the European Union (EU) Regulations (Article 17), released on April 5, 2017, mandated the use of third-party reprocessing services by all French hospitals.

Regional Growth Analysis:

Geographically, the global medical device reprocessing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to its well-established healthcare industry, growing prevalence of chronic diseases, and increasing volume of surgical procedures. The European region is expected to witness the highest CAGR during the forecast period, owing to the rising prevalence of chronic diseases, increasing geriatric population, rising healthcare expenditure, increasing number of surgical procedures, and growing awareness about the usage of reprocessed medical devices

Gas Chromatography Market To Reach USD 3.5 Billion By 2025 – Statistics & Growth Dynamics To 2025

 What This Report Will Provide?

The global gas chromatography (GC) market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key strategies.

Expected Revenue Growth:

[166 Pages Report] The global GC market size is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.1%.

Major Growth Boosters:

The growth in this market is driven by the increasing adoption of GC-MS, rising crude & shale oil production, increasing importance of wastewater treatment, rising food safety concerns, and growing use of chromatography tests in the drug approval process. However, the high cost of GC equipment, geopolitical issues prevailing in some countries, and shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101656773

Critical questions answered in the report:

• How will the current technological developments affect the GC market in the long term?
• What are the reasons contributing to the growth of the various segments in the GC market?
• Which regions are likely to grow at the highest CAGR?
• What are the challenges hindering the adoption of GC solutions?
• What are the growth strategies being implemented by major market players?

Key developments:

• In 2019, Agilent launched the 990 Micro GC System. The system is designed to monitor calorific valuation and odorant levels in natural gas. It is a compact and rugged system that may be used in laboratories
• In 2018, The University of Duisburg Essen collaborated with Agilent to utilize its gas and liquid chromatography systems and a variety of its mass spectrometry instruments to conduct improved research studies.
• In 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. This acquisition will allow PerkinElmer to expand its customer base for analytical instruments in China.

Oil and Gas is expected to rise in the forecast period in the end user segment

The Oil and Gas industry is growing at a CAGR of 4.1% in the end user market of GC. The growth is mainly attributed toincreasing crude & shale oil production and improved gas chromatography columns for the petroleum industry.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=101656773 

The columns segment will grow at the highest rate during the forecast period.

On the basis of accessories and consumables, the GC market is divided into columns, columns accessories, autosampler accessories, flow management accessories, consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is estimated to account for the largest share in the global gas chromatography market. The large share of this segment can primarily be attributed to factors such as improved gas chromatography columns for the petroleum industry.

 

Regional Growth Analysis:

North America is expected to account for the largest share of the global GC market. Market growth in this region is driven primarily by the increase in R&D funding, cannabis research, market for shale oil and gas, and food and agricultural industry. On the other hand, the Asia Pacific is projected to have the highest growth rate during the forecast period. The high growth rate of the region can be attributed to factors such as extensive sales of generics in Japan and the growth in the pharma and biotech sectors in India and China.

Pharmacy Automation Market To Reach USD 5.38 Billion By 2022 – Increasing Investment In Retail Pharmacy

 What This Report Will Provide?

The systems for managing medicines have remained largely unchanged for decades, while medications have increased in number and complexity, resulting in potentially greater risks for error. In addition, with the traditional methods of operation within pharmacies, pharmacists have witnessed various issues such as an increase in medication errors and growing patient waiting times, due to the increasing patient load.  

Expected Revenue Growth:

[218 Pages Report] MarketsandMarkets forecasts the pharmacy automation market is estimated to grow from USD 3.63 billion in 2017 to USD 5.38 Billion by 2022, at a Compound Annual Growth Rate (OTC:CAGR) of 8.2% during the forecast period.

Major Growth Boosters:

The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost. On the other hand, reluctance among the healthcare organizations to adopt pharmacy automation systems is expected to restrain the overall market growth to a certain extent during the forecast period.

The objective of the report is to define, describe, and forecast the pharmacy automation market size based on product, end user, and region.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71522890 

Recent Developments :

• In 2017, Omnicell launched Omnicell VBM 200F. It fills and checks SureMed multiple medication blister cards
• In 2017, Omnicell partnered with DCH Health Systems to implement a full suite of IV compounding technology across its health system
• In 2017, BD opened its new institute for medication management excellence. This institute is designed to identify and support advancements in medication management to help improve the safety and cost of healthcare
• In 2016, Omnicell acquired Ateb, Inc., which provides pharmacy-based patient care solutions and medication synchronization to independent and chain pharmacies
• In 2015, BD acquired CareFusion Corporation, a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room & procedural effectiveness, and respiratory care

Critical questions the report answers:

• Where will all these developments take the industry in the long term?
• What are the upcoming trends for the pharmacy automation market?
• Which segment provides the most opportunity for growth?
• Who are the leading players operating in this market?
• What are the opportunities for new market entrants?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=71522890 

Growing need to minimize medication errors :

Medication errors and dispensing errors are recognized as leading causes of hospital readmissions across the globe. A medication error can occur due to a variety of factors such as poor order communication between the physician and pharmacist, dangerous storage practices in pharmacies, and confusion arising out of the use of similar labels. Automated systems are considered to be one of the most efficient solutions to minimize these errors.

Regional Growth Analysis:

North America is expected to hold the largest market size in the pharmacy automation market during the forecast period, followed by the European region. The large share of the North American pharmacy automation market can largely be attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America and also the presence of a large number of pharmacy automation companies.

Glycomics / Glycobiology Market To Reach USD 2.0 Billion By 2025, At A CAGR Of 13.8%

 What This Report Will Provide?

This study involved four major activities in estimating the current size of the glycomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[173 Pages Report] The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.

Major Growth Boosters:

The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.

Download PDF Brochure: Download PDF Brochure - Glycomics Market - Forecasts to 2025 |

 Developments:

• In June 2019, Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System
• In June 2018, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.

Key Questions Addressed in The Report:

• Where will all these developments take the industry in the mid-to-long term?
• What are the recent trends affecting the glycomics market?
• Who are the key players in the market, and how intense is the competition?
• What are the key applications of glycomics?
• Which region is lucrative for the market?

Request Sample Report: Sample Request - Glycomics Market - Forecasts to 2025 | MarketsandMarkets

The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast period

Based on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.

Regional Growth Analysis:

The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing investments in glycomics research, rising R&D investments in pharmaceutical companies for drug discovery and the presence of all key players.

Western Blotting Market To Reach USD 730.7 Million By 2021 – Analysis Of Emerging Growth Factors

 What This Report Will Provide?

Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.

Expected Revenue Growth:

[169 Pages Report] The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).

Major Growth Boosters:

The growth of the overall market can be attributed to the increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711 

Stakeholders of the Western Blotting Market :

• Western Blotting Instruments and Consumables Manufacturing Companies
• Suppliers and Distributors of Western Blotting Instruments and Consumables
• Research and Consulting Firms
• Research Institutes
• Venture Capitalists

Western Blotting Market, by Application

• Biomedical & Biochemical Research
• Disease Diagnostics
• Agriculture
• Other Applications (quality control and biologics)

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711 

The global market, based on the application is segmented into biomedical & biochemical research, disease diagnostics, agriculture, disease diagnostics, biologics, and quality control, among others. The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021.

Regional Growth Analysis:

In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.

North America is expected to account for the largest share of the global market. This can be attributed to the increasing prevalence of HIV and Lyme disease in the U.S., rise in research funding and increasing production of genetically modified crops in the U.S., U.S.-China collaborative program for biomedical research, and HIV vaccine initiative in Canada.

Aesthetic Lasers Market : Rising Adoption Of Branded Beauty And Cosmetic Products

 What This Report Will Provide?

Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period.

Expected Revenue Growth:

The global aesthetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021.

Major Growth Boosters:

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.

Increasing preference for noninvasive cosmetic procedures, increasing disposable income, technological advancements, and rising medical tourism are the major drivers of the aesthetic lasers market. However, lack of reimbursement will restrain the growth of this market.

Download PDF Brochure: Download PDF Brochure - Aesthetic Lasers Market | Growing at a CAGR of 10.2% | MarketsandMarkets

Target Audience:

• Aesthetic/Cosmetic Lasers Manufacturers
• Aesthetic/Cosmetic Lasers Distributors and Wholesalers
• Various Research and Consulting Firms
• Research Institutes
• Contract Manufacturing Organizations (CMOS)
• Original Equipment Manufacturers (OEMs)

Market, by Application

• Vascular Lesions, Acne, & Scars
• Pigmented Lesions & Tattoos
• Hair Removal
• Skin Rejuvenation
• Leg Veins & Varicose Veins
• Other Applications (Onychomycosis, Gynecological Conditions)

Request Sample Report:  Sample Request - Aesthetic Lasers Market | Growing at a CAGR of 10.2% | MarketsandMarkets

Based on application, the aesthetic/cosmetic lasers type market is segmented into vascular lesions, acne & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynecological conditions). The hair removal segment accounted for the largest share of the market due to factors such as high adoption of aesthetic procedures, developments in the laser technology, increased focus on body appearance, and high disposable income.

Regional Growth Analysis:

The market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global aesthetic lasers market. However, the Asia-pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to factors changing lifestyles, rising incidences of skin damage, and increasing medical tourism in the region will drive the growth of this market.

Laboratory Filtration Market To Reach USD 4.1 Billion By 2025 - Growing Demand For Nanofiltration

 What This Report Will Provide?

The study involved four major activities in estimating the current size of the laboratory filtration market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizes with industry experts across the value chain through primary research.

Expected Revenue Growth :

[221 Pages Report] The global laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period.

Major Growth Boosters :

Growth in this market is driven majorly by the rising R&D spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082 

Key Questions Addressed in the Report

• Which are the top 10 players operating in the lab filtration market?
• What are the drivers, restraints, opportunities, and challenges of the market?
• What are the prevailing industry trends, and what is the current scenario in the market?
• What are the growth trends in the market at the segmental and overall levels?
• How is the Lab filtration market performing in different regions across the globe?

Which is the leading product type of laboratory filters?

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories). The filtration media segment accounted for the largest market share in 2018.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082 

Which is the leading application for single-cell analysis instruments and consumables?

Based on application, the laboratory filtration market is segmented into research and medical applications. The research applications segment accounted for the largest share of the laboratory filtration market in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.

Regional Growth Analysis:

The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.

North American Nuclear Medicine Market To Reach USD 2.7 Billion By 2024 – Expansion In Emerging Economies

 What This Report Will Provide?

The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[159 Pages Report] The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period

Major Growth Boosters:

Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.

Download PDF Brochure: Download PDF Brochure - North American Nuclear Medicine Market - Global Forecast to 2024 | MarketsandMarkets

Key Questions Addressed in The Report:

• Which product segment will dominate the North American nuclear medicine market in the future?
• Which application segment will dominate the market in the future?
• Emerging countries offer immense opportunities for the growth and adoption of nuclear medicine; will this scenario continue in the coming five years?
• Where will technology advancements offered by various companies take the industry in the mid- to long-term?
• What are the upcoming products in the nuclear medicine market?

The alpha emitters segment is expected to command the largest share of the therapeutic nuclear medicine market in 2019

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes. In 2013, the FDA approved the first and only product for alpha emitters in the market, launched by Bayer AG under the name Xofigo (a Ra-223 dichloride molecule). The North American market for Ra-223 is expected to command the largest share owing to its targeted properties over beta emitters and being the only alpha-emitter product available in the market.

Request Sample Report: Sample Request - North American Nuclear Medicine Market - Global Forecast to 2024 | MarketsandMarkets

On the basis of type, which segment will command the largest market share?On the basis of type, North America nuclear medicine market is segmented into diagnostic and therapeutic North America nuclear medicine. The diagnostic North America nuclear medicine market accounted for the largest share of the North America nuclear medicine market. The rising prevalence of cancer and cardiovascular diseases, increasing use of SPECT and PET imaging and advancements in radiotracers are driving the growth of this segment.

Regional Growth Analysis:

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Vaccine Adjuvants Market To Reach USD 769.4 Million by 2021 – Increasing Investment In vaccine immunization

 What This Report Will Provide?

The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets has opened an array of opportunities for the market. However, the high cost of adjuvant-based research and proven safety of adjuvants are hampering the growth of the global market.

Expected Revenue Growth:

[156 Pages Report] The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.

Major Growth Boosters:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

Target Audience for this Report:

• Vaccine adjuvants manufacturers and suppliers
• Academic research institutes
• Biopharmaceutical and biotechnology companies
• Research and development (R&D) companies
• Business research and consulting service providers
• Medical research laboratories
• Academic medical centers and universities

Value Addition for the Buyer:

This report aims to provide insights into the global vaccine adjuvants market. It provides valuable information on the product type, route of administration, disease type, applications, and application categories in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High prevalence of infectious diseases and increasing funding for adjuvant research will drive the growth of this market segment.

Regional Growth Analysis:

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.